-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
in Psychiatry |
|
Submit your manuscript
Scope
The Aging Psychiatry Section is a modern, agile forum to illuminate uncertainties in aging, and to examine the root of prejudices towards old age. The ultimate goal is to contribute to the improvement of mental health in old age, and thus our quality of life. We welcome clinical and research findings, as well as perspectives, hypotheses, systematic reviews and meta-analyses.
Scope
As our knowledge of health and medicine grows, our life expectancy is increased – but furthermore, these advances have to add “life to our years” by improving our health in later life. This longevity highlights the importance of further attention to health and disease and, from a preventative perspective to maintaining good health, the determinants of successful biopsychosocial aging are fundamental. Thus, the focus of the Aging Psychiatry Section begins in adulthood when aging brain processes are already evident, and even in early life when associated developmental and aging processes start to occur. Beyond psychiatry, more general contributions from interdisciplinary areas of neuroscience, such as neuropsychopharmacology, experimental neuropsychobiology, psychoneuroimmunology, neuroimaging, genetics, proteomics, neuropsychiatry, neuropsychology and psychology are necessary and welcome to disentangle mechanisms of psychiatric disorders in old age populations. Aging Psychiatry is a translational platform that promotes collaboration between neuroscientists and clinicians in a translational perspective.
The main focus of Aging Psychiatry is broad to allow for a great range of groundbreaking discourse. We welcome manuscripts that clarify the following areas including, but not limited to:
• The link between mechanisms and the course of neurodegenerative/psychiatric disorders, and associated treatment responses.
• The role of cognitive/neural reserve and resilience.
• The importance of new disease models.
• How to identify new biomarkers of diagnosis and treatment response.
• The role of Illness onset (early versus late) and course (chronic, episodic, recurrent) on the mechanisms, phenomenology and treatment response.
• The role of comorbidity with other medical and neurological illnesses.
• Methods to reduce healthcare costs by improving social aspects and treatment response.
• How the prevention of neurodegenerative disorders impacts epidemiology.
• Pharmacokinetics and pharmacodynamics, treatment efficacy, and side effects of different drug treatments, in order to bridge the gap in knowledge between adult and aging psychiatry.
• Discourse on whether nutraceuticals and diet have a role in prevention and/or pathogenetic treatment.
• The role of motor activity/rehabilitation and traditional medicine in neurodegeneration associated psychiatric disorders.
• The role of personalised drug and rehabilitation treatments.
Aging Psychiatry is a modern, agile forum to illuminate uncertainties in aging, and to examine the root of prejudices towards old age. The ultimate goal is to contribute to the improvement of mental health in old age, and thus our quality of life. We welcome clinical and research findings, as well as perspectives, hypotheses, systematic reviews and meta-analyses.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO, EMBASE, Science Citation Index Expanded, CLOCKSS, Social Science Citation Index
PMCID: NA
Aging Psychiatry welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Data Report, Editorial, Hypothesis and Theory, Mini Review, Opinion, Original Research, Perspective, Registered Report, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Aging Psychiatry, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Aging Psychiatry will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Psychiatry.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact psychiatry.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact psychiatry@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org